13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001502287
Total reported value
$2.2B
$2.2B
14 檔
10.8%
In Q3 2024, StepStone Group LP's U.S. equity holdings reached a combined market value of $2.2B, distributed across 14 disclosed stock positions.
In Q3 2024, StepStone Group LP adopted a defensive or profit-taking posture, trimming 2 positions and completely liquidating 4 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including DNB, MONEYLION INC, RBLX) accounted for 10.8% of total reported equity market value during Q3 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DNB | Dun & Bradstreet Holdings In | Stock-Other | 55.52% | — | -36.27% | |
| 2 | ✓ | Moneylion Inc | Stock-Other | 9.44% | — | — | |
| 3 | RBLX | Roblox CORP -class A | Stock-Comm Services | 7.54% | — | — | |
| 4 | RKLB | Rocket Lab Corporation | Stock-Industrials | 6.88% | — | -76.40% | |
| 5 | PATH | Uipath Inc - Class A | Stock-Tech | 6.01% | -4.83% | EXIT | |
| 6 | DKNG | Draftkings Inc-cl A | Stock-Consumer Disc | 4.60% | -1.68% | EXIT | |
| 7 | TRDA | Entrada Therapeutics Inc | Stock-Other | 4.44% | -4.37% | — | |
| 8 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 2.78% | -2.05% | — | |
| 9 | ✓ | Neuehealth Inc | Stock-Other | 1.00% | — | +0.40% | |
| 10 | FRSH | Freshworks Inc-cl A | Stock-Other | 0.59% | — | — | |
| 11 | ✓ | Hillevax Inc | Stock-Other | 0.53% | — | — | |
| 12 | TNYA | Tenaya Therapeutics Inc | Stock-Other | 0.33% | -0.13% | — | |
| 13 | GROV | Grove Collaborative Holdings | Stock-Other | 0.19% | -0.21% | — | |
| 14 | ✓ | Vacasa Inc | Stock-Other | 0.15% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | DNB | Dun & Bradstreet Holdings In | +16.6% | -36.27% | Trim |
| 2 | DKNG | Draftkings Inc-cl A | +4.6% | NEW | New buy |
| 3 | RBLX | Roblox CORP -class A | +4% | — | Unchanged |
| 4 | PATH | Uipath Inc - Class A | +2.7% | — | Unchanged |
| 5 | TRDA | Entrada Therapeutics Inc | +2.2% | — | Unchanged |
| 6 | PHAT | Phathom Pharmaceuticals Inc | +1.9% | — | Unchanged |
| 7 | FRSH | Freshworks Inc-cl A | +0.6% | NEW | New buy |
| 8 | ✓ | Neuehealth Inc | +0.4% | +0.40% | Add |
| 9 | ✓ | Moneylion Inc | +0.2% | — | Unchanged |
| 10 | GROV | Grove Collaborative Holdings | +0.1% | — | Unchanged |
| 11 | TNYA | Tenaya Therapeutics Inc | 0% | — | Unchanged |
| 12 | ✓ | Vacasa Inc | — | — | Unchanged |
| 13 | FINV | Finvolution Group-adr | -0.1% | EXIT | Sold out |
| 14 | 628 | Semrush Holdings Inc-a | -0.1% | EXIT | Sold out |
| 15 | ✓ | Doma Holdings Inc | -0.7% | EXIT | Sold out |
| 16 | RKLB | Rocket Lab Corporation | -1.1% | -76.40% | Trim |
| 17 | ✓ | Hillevax Inc | -1.9% | — | Unchanged |
| 18 | ✓ | Walkme LTD | -29.4% | EXIT | Sold out |
According to official SEC Form 13F filings, StepStone Group LP reported a total U.S. public equity portfolio value of $2.2B across 14 disclosed positions in Q3 2024.
During Q3 2024, StepStone Group LP's top holdings by market value included DNB (55.5%)、MONEYLION INC (9.4%)、RBLX (7.5%). The largest single position, DNB, represented 55.5% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
DKNG
市值: $12.6M
Top Position Liquidated / Trimmed
WALKME LTD
前期市值: $144.8M
In Q3 2024, StepStone Group LP made 9 total portfolio adjustments, initiating 2 new buys, adding to 1 positions, trimming 2 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.